Securities code: Bloomage Biotechnology Corporation Limited(688363) securities abbreviation: Bloomage Biotechnology Corporation Limited(688363) Announcement No.: 2022004 Bloomage Biotechnology Corporation Limited(688363)
Announcement of main business data from January to February 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
1、 Main operating data from January to February 2022
From January to February 2022, Bloomage Biotechnology Corporation Limited(688363) (hereinafter referred to as “the company”) carried out various businesses in an orderly manner according to the established strategy, among which the functional skin care products sector continued to grow strongly. After preliminary accounting, from January to February 2022, the company achieved a total operating revenue of about 640 million yuan, a year-on-year increase of about 55%.
2、 Explanatory matters
The above main operating data are preliminary accounting data, which are only used as phased financial data for investors’ reference, and can not be used to calculate the company’s annual performance. Please invest rationally and pay attention to risks.
It is hereby announced.
Bloomage Biotechnology Corporation Limited(688363) board of directors March 10, 2022
